...
首页> 外文期刊>ANZ journal of surgery >Surgical outcome of superficial and deep castleman disease.
【24h】

Surgical outcome of superficial and deep castleman disease.

机译:浅表性和深部Castleman病的手术结局。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Castleman disease is a rare lymphoproliferative disease of low malignant potential occurring in two forms, unicentric and multicentric. Surgery, chemotherapy, immunotherapy and radiation therapy have all been used to manage the disease. In this study, we evaluate whether the site of the lesions, that is, superficial or deep, influences the surgical outcome. Methods: We retrospectively reviewed the records of 20 patients operated on for Castleman disease from 1994 to 2003, of whom 11 patients had superficial disease and 9 had deep lesions. The end-points of this study were survival and recurrence. Results: Of the 20 patients, 19 had unicentric (cervical in 8, mediastinal in 5, retroperitoneal in 2, axillary in 2, hepatic in 1, and mesenteric in 1) and 1 had multicentric Castleman disease. Among 19 patients who had complete resection (18 with unicentric and 1 with multicentric disease), there has been no evidence of recurrence. Conclusion: Whether Castleman disease is superficial or deep has no effect on surgical outcome as long as resection is complete.
机译:背景:Castleman病是一种罕见的低恶性淋巴增生性疾病,以单中心和多中心两种形式出现。外科手术,化学疗法,免疫疗法和放射疗法均已用于控制该疾病。在这项研究中,我们评估病变的部位(即浅表或深部)是否会影响手术效果。方法:回顾性分析1994年至2003年手术治疗的20例Castleman病患者的记录,其中浅表疾病11例,深部病变9例。这项研究的终点是生存和复发。结果:20例患者中,单中心性19例(宫颈8例,纵隔5例,腹膜后2例,腋下2例,肝1例,肠系膜1例),多发性Castleman病1例。在19例完全切除的患者中(18例单中心切除,1例多中心病变),没有复发的证据。结论:只要切除完成,Castleman病是浅表性还是深部性对手术结果均无影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号